Sunday, March 15, 2020 10:17:46 AM
LH BUY ALERT: Recent $196.00 high. Gaped down on Coronavirus/Stock Market fears to $134.- AFTER LH announced Coronavirus testing kit March 5th. LH consistently does 500mm lab tests per year, $11B/yr in GR, is profitable, generates ~$1B in cash each year & usually price stable w/ 94% Institutional Ownership!
Chart: The stock normally corrects HARD UPWARDS after a break down into oversold (RSI below 30), as we are seeing now.
LH (COVID-19) Test & PR here:
https://www.labcorp.com/information-labcorp-about-coronavirus-disease-2019-covid-19
LabCorp (LH) mentioned SEVEN TIMES in this press conference:
https://thehill.com/video/administration/487431-watch-live-trump-holds-press-conference-on-coronavirus
Transcript:
https://www.rev.com/blog/transcripts/donald-trump-speech-transcript-declares-coronavirus-national-emergency
LH is global, in 100 countries, partnered with Walgreens, & now ALL OVER the news as TESTING for the virus (until ~18mos when a vaccine is expected).
NOTE: In the ~20min since POTUS Coronavirus "State of Emergency" speech urging TESTING, LH doubled in volume. From average (of ~800k) to close up from what NOW APPEARS to be a bottom. Stock is still down ~25% from near $200.00 levels despite being a MAJOR Coronavirus player, solution, & having no fundamental reason for a price correction.
We are NOT talking about the airline industry, travel, cruise-lines, restaurants, retail, or anything else that may temporarily be dead money, with uncertainty, & therefore grind to a HALT. LH is a SOLUTION to the Coronavirus pandemic & underpriced, undervalued, & had the market NOT closed on Friday ...or the televised POTUS "State of Emergency" occurred earlier, LH stock price might have broken UP THROUGH previous highs! Since in 20min prior to close, LH traded almost ALL the days' previous VOLUME in those 20min. Should we see that trend continue Monday into the week, LH will be a WINNER amongst a skittish stock market filled with near-term uncertainty. But NOT for this undervalued stock with a CENTRAL ROLE to play in this growing pandemic crisis.
I guess we'll see what happens Monday. But I'm calling the stock @ $150 (& off 25% from recent-highs for no real discernable reason) a STRONG BUY at these levels into next week.
Recent LH News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 08:05:59 PM
- Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience • PR Newswire (US) • 09/18/2024 11:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/18/2024 10:12:36 AM
- LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034 • PR Newswire (US) • 09/16/2024 10:35:00 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 09/16/2024 09:30:56 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/16/2024 12:21:09 PM
- Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health • PR Newswire (US) • 09/16/2024 11:30:00 AM
- Labcorp to Speak at the Baird 2024 Global Healthcare Conference • PR Newswire (US) • 09/03/2024 08:09:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 02:16:00 PM
- Labcorp Finalizes Acquisition of Select Assets of Invitae • PR Newswire (US) • 08/05/2024 11:00:00 AM
- Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx • PR Newswire (US) • 08/02/2024 12:30:00 PM
- Labcorp Announces 2024 Second Quarter Results • PR Newswire (US) • 08/01/2024 10:57:00 AM
- Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities • PR Newswire (US) • 07/30/2024 11:00:00 AM
- Labcorp Declares Quarterly Dividend • PR Newswire (US) • 07/25/2024 10:59:00 AM
- Labcorp to Announce Second Quarter Financial Results on August 1, 2024 • PR Newswire (US) • 07/01/2024 11:00:00 AM
- Labcorp Launches Global Trial Connect to Accelerate Clinical Trials • PR Newswire (US) • 06/17/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 12:52:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:41:13 AM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 06/03/2024 09:23:56 PM
- Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio • PR Newswire (US) • 06/03/2024 11:00:00 AM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/30/2024 05:18:28 PM
- Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting • PR Newswire (US) • 05/30/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 11:04:15 AM
- Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference • PR Newswire (US) • 05/28/2024 10:59:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/17/2024 08:57:17 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM